Structural Formula (Image 1)
Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 71205-454
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 71205-454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Image 2)
Image (Image 3)
Image (Image 4)
Image (Image 5)
Image (Image 6)
Image (Image 7)
71205-454-42 (Image 8)
This is a description of Cyclobenzaprine HCI extended-release capsules with a strength of 15mg. Each capsule contains Cyclobenzaprine hydrochloride USP, 15 mg. The medication is available only with a prescription and comes in a bottle of 30 capsules. The capsules are hard gelatin with a dark orange opaque cap and red opaque body, imprinted with "T035" in black ink. The manufacturer is TWi Pharmaceuticals, Inc. in Taoyuan City, Tawan. The medication should be kept out of the reach of children. The capsules are packaged by Proficient Rx LP in Thousand Oaks, California. There is some additional information on the lot numbers and expiration dates.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
